Instil Bio Statistics
Total Valuation
Instil Bio has a market cap or net worth of $51.41 million. The enterprise value is $69.15 million.
| Market Cap | 51.41M |
| Enterprise Value | 69.15M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Instil Bio has 6.78 million shares outstanding. The number of shares has increased by 3.61% in one year.
| Current Share Class | 6.78M |
| Shares Outstanding | 6.78M |
| Shares Change (YoY) | +3.61% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.02% |
| Owned by Institutions (%) | 19.11% |
| Float | 3.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.67, with a Debt / Equity ratio of 0.81.
| Current Ratio | 21.67 |
| Quick Ratio | 21.09 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.88 |
Financial Efficiency
Return on equity (ROE) is -25.33% and return on invested capital (ROIC) is -11.23%.
| Return on Equity (ROE) | -25.33% |
| Return on Assets (ROA) | -10.77% |
| Return on Invested Capital (ROIC) | -11.23% |
| Return on Capital Employed (ROCE) | -19.00% |
| Weighted Average Cost of Capital (WACC) | 9.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.78M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.08% in the last 52 weeks. The beta is 1.91, so Instil Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.91 |
| 52-Week Price Change | -70.08% |
| 50-Day Moving Average | 7.48 |
| 200-Day Moving Average | 8.80 |
| Relative Strength Index (RSI) | 59.22 |
| Average Volume (20 Days) | 7,652 |
Short Selling Information
The latest short interest is 189,165, so 2.79% of the outstanding shares have been sold short.
| Short Interest | 189,165 |
| Short Previous Month | 203,828 |
| Short % of Shares Out | 2.79% |
| Short % of Float | 5.22% |
| Short Ratio (days to cover) | 15.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -36.95M |
| Pretax Income | -30.28M |
| Net Income | -30.28M |
| EBITDA | -36.66M |
| EBIT | -36.95M |
| Earnings Per Share (EPS) | -$4.47 |
Balance Sheet
The company has $69.68 million in cash and $87.42 million in debt, with a net cash position of -$17.74 million or -$2.62 per share.
| Cash & Cash Equivalents | 69.68M |
| Total Debt | 87.42M |
| Net Cash | -17.74M |
| Net Cash Per Share | -$2.62 |
| Equity (Book Value) | 107.38M |
| Book Value Per Share | 15.83 |
| Working Capital | 68.30M |
Cash Flow
| Operating Cash Flow | -23.61M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 284,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -23.61M |
| FCF Per Share | -$3.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Instil Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.61% |
| Shareholder Yield | -3.61% |
| Earnings Yield | -58.90% |
| FCF Yield | -45.93% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Dec 8, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |